Extracellular nucleotides as negative modulators of immunity

被引:94
作者
Di Virgilio, Francesco [1 ]
Boeynaems, Jean-Marie [2 ,3 ,4 ]
Robson, Simon C. [5 ,6 ]
机构
[1] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy
[2] Univ Libre Bruxelles, Sch Med, Brussels, Belgium
[3] Erasme Univ Hosp, Dept Lab Med, Brussels, Belgium
[4] Erasme Univ Hosp, IRIBHM, Brussels, Belgium
[5] Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA USA
[6] Harvard Univ, Boston, MA 02115 USA
关键词
HUMAN DENDRITIC CELLS; ADENOSINE 5'-TRIPHOSPHATE; HUMAN BLOOD; NEUTROPHIL CHEMOTAXIS; SIGNALING MOLECULES; P2; RECEPTORS; ATP; INFLAMMATION; RELEASE; DESENSITIZATION;
D O I
10.1016/j.coph.2009.06.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nucleotides are well known for being the universal currency of intracellular energy transactions, but over the past decade it has become clear that they are also ubiquitous extracellular messengers. In the immune system there is increasing awareness that nucleotides serve multiple roles as stimulants of lymphocyte proliferation, ROS generation, cytokine and chemokine secretion: in one word as pro-inflammatory mediators. However, although often neglected, extracellular nucleotides exert an additional more subtle function as negative modulators of immunity, or as immunedepressants. The more we understand the peculiar biochemical composition of the microenvironment generated at inflammatory sites, the more we appreciate how chronic exposure to low extracellular nucleotide levels affect immunity and inflammation. A deeper understanding of this complex network will no doubt help design more effective therapies for cancer and chronic inflammatory diseases.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 43 条
  • [1] Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer
    Agteresch, HJ
    Dagnelie, PC
    van der Gaast, A
    Stijnen, T
    Wilson, JH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04) : 321 - 328
  • [2] ATP drives lamina propria TH17 cell differentiation
    Atarashi, Koji
    Nishimura, Junichi
    Shima, Tatsuichiro
    Umesaki, Yoshinori
    Yamamoto, Masahiro
    Onoue, Masaharu
    Yagita, Hideo
    Ishii, Naoto
    Evans, Richard
    Honda, Kenya
    Takeda, Kiyoshi
    [J]. NATURE, 2008, 455 (7214) : 808 - U10
  • [3] Differential regulation and relocalization of the platelet P2Y receptors after activation:: A way to avoid loss of hemostatic properties?
    Baurand, A
    Eckly, A
    Hechler, B
    Kauffenstein, G
    Galzi, JL
    Cazenave, JP
    Léon, C
    Gachet, C
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (03) : 721 - 733
  • [4] Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis
    Beldi, Guido
    Wu, Yan
    Banz, Yara
    Nowak, Michael
    Miller, Lindsay
    Enjyoji, Keiichi
    Haschemi, Arvand
    Yegutkin, Gennady G.
    Candinas, Daniel
    Exley, Mark
    Robson, Simon C.
    [J]. HEPATOLOGY, 2008, 48 (03) : 841 - 852
  • [5] Effects of intestinal microflora and the environment on the development of asthma and allergy
    Björkstén, B
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 25 (3-4): : 257 - 270
  • [6] Gene expression profiling defines ATP as a key regulator of human dendritic cell functions
    Bles, Nathalie
    Horckmans, Michael
    Lefort, Anne
    Libert, Frederic
    Macours, Pascale
    El Housni, Hakim
    Marteau, Frederic
    Boeynaems, Jean-Marie
    Communi, Didier
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 179 (06) : 3550 - 3558
  • [7] Modulation of inflammation by extracellular nucleotides
    Boeynaems, Jean-Marie
    Communi, Didier
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (05) : 943 - 944
  • [8] Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
    Bours, M. J. L.
    Swennen, E. L. R.
    Di Virgilio, F.
    Cronstein, B. N.
    Dagnelie, P. C.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 112 (02) : 358 - 404
  • [9] Pathophysiology and therapeutic potential of purinergic signaling
    Burnstock, G
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (01) : 58 - 86
  • [10] The past, present and future of purine nucleotides as signalling molecules
    Burnstock, G
    [J]. NEUROPHARMACOLOGY, 1997, 36 (09) : 1127 - 1139